Trial Profile
Efficacy and safety of the single catch-up dose of tick-borne encephalitis vaccine (FSME-IMMUN) in subjects with irregular vaccination schedules
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis virus infections
- Focus Therapeutic Use
- 30 Dec 2015 New trial record